SQUAWK/NEWS
Menu
Live News EQUITY L impact

Sangamo Therapeutics Files SEC Form

Sangamo Therapeutics submits filing to SEC, details not specified

SGMO

Filed: 2026-05-27 AccNo: 0002041855-26-000010 Size: 5 KB